Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conservation of antiviral systems across domains of life reveals immune genes in humans.
Cury J, Haudiquet M, Hernandez Trejo V, Mordret E, Hanouna A, Rotival M, Tesson F, Bonhomme D, Ofir G, Quintana-Murci L, Benaroch P, Poirier EZ, Bernheim A. Cury J, et al. Among authors: bonhomme d. Cell Host Microbe. 2024 Sep 11;32(9):1594-1607.e5. doi: 10.1016/j.chom.2024.08.002. Epub 2024 Aug 28. Cell Host Microbe. 2024. PMID: 39208803
Early signaling pathways in virus-infected cells.
Bonhomme D, Poirier EZ. Bonhomme D, et al. Curr Opin Virol. 2024 Jun;66:101411. doi: 10.1016/j.coviro.2024.101411. Epub 2024 May 7. Curr Opin Virol. 2024. PMID: 38718574 Free article. Review.
Corrigendum: Escape of TLR5 recognition by Leptospira spp.: A rationale for atypical endoflagella.
Holzapfel M, Bonhomme D, Cagliero J, Vernel-Pauillac F, d'Andon MF, Bortolussi S, Fiette L, Goarant C, Wunder EA Jr, Picardeau M, Ko AI, Werling D, Matsui M, Boneca IG, Werts C. Holzapfel M, et al. Among authors: bonhomme d. Front Immunol. 2022 Nov 8;13:932151. doi: 10.3389/fimmu.2022.932151. eCollection 2022. Front Immunol. 2022. PMID: 36439189 Free PMC article.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Portal-Celhay C, Forleo-Neto E, Eagan W, Musser BJ, Davis JD, Turner KC, Norton T, Hooper AT, Hamilton JD, Pan C, Mahmood A, Baum A, Kyratsous CA, Kim Y, Parrino J, Kampman W, Roque-Guerrero L, Stoici R, Fatakia A, Soo Y, Geba GP, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; COVID-19 Phase 2 Dose-Ranging Study Team. Portal-Celhay C, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2225411. doi: 10.1001/jamanetworkopen.2022.25411. JAMA Netw Open. 2022. PMID: 35969402 Free PMC article. Clinical Trial.
Alive Pathogenic and Saprophytic Leptospires Enter and Exit Human and Mouse Macrophages With No Intracellular Replication.
Santecchia I, Bonhomme D, Papadopoulos S, Escoll P, Giraud-Gatineau A, Moya-Nilges M, Vernel-Pauillac F, Boneca IG, Werts C. Santecchia I, et al. Among authors: bonhomme d. Front Cell Infect Microbiol. 2022 Jul 11;12:936931. doi: 10.3389/fcimb.2022.936931. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35899053 Free PMC article.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Herman GA, O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Musser BJ, Davis JD, Turner KC, Mahmood A, Hooper AT, Hamilton JD, Parrino J, Subramaniam D, Baum A, Kyratsous CA, DiCioccio AT, Stahl N, Braunstein N, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. Herman GA, et al. Lancet Infect Dis. 2022 Oct;22(10):1444-1454. doi: 10.1016/S1473-3099(22)00416-9. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803290 Free PMC article. Clinical Trial.
42 results